Arsenault Ryan, Marshall Steven, Salois Patrick, Li Qiao, Zhang Wandong
Human Health Therapeutics Research Centre, National Research Council of Canada, Ottawa, ON K1A 0R6, Canada.
Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Biology (Basel). 2024 Jan 30;13(2):87. doi: 10.3390/biology13020087.
TREM2 is a critical innate immune receptor primarily expressed on myeloid-derived cells, such as microglia and macrophages. Mutations in TREM2 are linked to several neurodegenerative diseases including Alzheimer's disease (AD). TREM2 can be cleaved from the cell membrane and released as soluble TREM2 (sTREM2). sTREM2 levels are shown to peak prior to AD, with its levels fluctuating throughout disease progression. However, the mechanism by which sTREM2 may affect innate immune responses is largely uncharacterized. In this study, we investigated whether sTREM2 can induce inflammatory response in myeloid-derived THP-1 monocytes and macrophages and characterized the signaling mechanisms involved. Our results show that sTREM2 was capable of stimulating the expression of several inflammatory cytokines in THP-1 cells throughout the time course of 2 h to 8 h but inducing anti-inflammatory cytokine expression at later time points. A TREM2 antibody was capable of inhibiting the expression of some cytokines induced by sTREM2 but enhancing others. The complex of sTREM2/TREM2 antibody was shown to enhance IL-1β expression, which was partially blocked by an NLRP3 specific inhibitor, indicating that the complex activated the NRLP3 inflammasome pathway. sTREM2 was also shown to have differential effects on cytokine expression in M0, M1, and M2 macrophages differentiated from THP-1 cells. sTREM2 has a more stimulating effect on cytokine expression in M0 macrophages, less of an effect on M2 macrophages, and some inhibitory effects on cytokine expression in M1 macrophages at early time points. Analyses of several signaling pathways revealed that sTREM2-induced expression of cytokines occurs mainly through MAPK-JNK signaling. Our work reveals differential effects of sTREM2 on cytokine expression profiles of THP-1 cells and macrophages and demonstrates that the MAPK-JNK signaling pathway is mainly responsible for sTREM2-induced cytokine expression.
触发受体表达于髓系细胞2(TREM2)是一种关键的固有免疫受体,主要表达于髓系来源的细胞,如小胶质细胞和巨噬细胞。TREM2的突变与包括阿尔茨海默病(AD)在内的多种神经退行性疾病有关。TREM2可从细胞膜上裂解下来,以可溶性TREM2(sTREM2)的形式释放。研究表明,sTREM2水平在AD发病前达到峰值,其水平在疾病进展过程中波动。然而,sTREM2影响固有免疫反应的机制在很大程度上尚未明确。在本研究中,我们调查了sTREM2是否能在髓系来源的THP-1单核细胞和巨噬细胞中诱导炎症反应,并对其中涉及的信号传导机制进行了表征。我们的结果表明,sTREM2能够在2小时至8小时的整个时间进程中刺激THP-1细胞中几种炎性细胞因子的表达,但在较晚时间点诱导抗炎细胞因子的表达。一种TREM2抗体能够抑制sTREM2诱导的一些细胞因子的表达,但增强其他细胞因子的表达。sTREM2/TREM2抗体复合物被证明能增强白细胞介素-1β(IL-1β)的表达,这被一种NLRP3特异性抑制剂部分阻断,表明该复合物激活了NRLP3炎性小体途径。sTREM2对从THP-1细胞分化而来的M0、M1和M2巨噬细胞中的细胞因子表达也有不同影响。sTREM2对M0巨噬细胞中的细胞因子表达有更强的刺激作用,对M2巨噬细胞的作用较小,在早期时间点对M1巨噬细胞中的细胞因子表达有一些抑制作用。对几种信号通路的分析表明,sTREM2诱导的细胞因子表达主要通过丝裂原活化蛋白激酶-应激活化蛋白激酶(MAPK-JNK)信号传导发生。我们的工作揭示了sTREM2对THP-1细胞和巨噬细胞细胞因子表达谱的不同影响,并证明MAPK-JNK信号通路是sTREM2诱导细胞因子表达的主要原因。